Literature DB >> 9383013

Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. Part II.

M Gattu1, A V Terry, J R Pauly, J J Buccafusco.   

Abstract

The adult spontaneously hypertensive rat (SHR) has been shown to exhibit a decrease in the expression and nicotine-stimulated function of brain nicotinic acetylcholine receptors, factors that could play a role in the impaired ability of this strain in the performance of learning and memory-related tasks. The purpose of this study was to determine whether either or both the impaired task performance and the loss of nicotinic receptors is directly related to the presence of the hypertensive state. To address this issue, two experimental approaches were taken. In the first series, 4-week-old pre-hypertensive SHR were tested in two phases of a water maze (spatial memory) task, and their performance was compared with that of two age-matched normotensive strains, Wistar Kyoto (WKY) and Wistar rats. During phase 1, SHR and WKY rats were not different in their ability to learn the task. In contrast, during phase 2 (subsequent series of trials after a 4 day inter-phase period), where rats were required to find a new platform location, SHR exhibited significantly impaired performance compared to both WKY and Wistar normotensive controls. In a single trial passive avoidance paradigm, SHR again displayed significantly reduced avoidance behavior as compared with both WKY and Wistar rats. In consecutive coronal sections the density of [3H]cytisine binding sites was decreased in pre-hypertensive SHR by up to 18% in about 40% of the brain regions examined, with the deficits particularly apparent in frontal cortex (layers 4-6), posterior subiculum, several thalamic regions, and the interpeduncular nucleus. In the second series, age-matched SHR and WKY were treated with the antihypertensive agent hydralazine administered in the drinking water beginning at 4 weeks of age. Hydralazine prevented the development of hypertension in adult SHR, but did not forestall the reduced expression of brain nicotinic receptors, nor the impairment in learning- and memory-related tasks normally observed in untreated adults with established hypertension. Moreover, the magnitude of nicotine-stimulated rubidium efflux from cortical and striatal synaptosomes in vitro was significantly reduced in samples derived from hydralazine-treated SHR as compared with those from hydralazine-treated, or untreated WKY. These results support the contention that the hypertensive state does not directly contribute to the reduced expression of nicotinic receptors in SHR. Therefore, the SHR may provide an important genetic model for the study of the role of central nicotinic receptors in cognitive and learning abnormalities.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9383013     DOI: 10.1016/s0006-8993(97)00794-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Chronic, severe hypertension does not impair spatial learning and memory in Sprague-Dawley rats.

Authors:  I Kadish; T van Groen; J M Wyss
Journal:  Learn Mem       Date:  2001 Mar-Apr       Impact factor: 2.460

Review 2.  The histamine H3 receptor: an attractive target for the treatment of cognitive disorders.

Authors:  T A Esbenshade; K E Browman; R S Bitner; M Strakhova; M D Cowart; J D Brioni
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

3.  Decreased α4β2 nicotinic receptor number in the absence of mRNA changes suggests post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD.

Authors:  Mattis B Wigestrand; Yann S Mineur; Christopher J Heath; Frode Fonnum; Marina R Picciotto; Sven Ivar Walaas
Journal:  J Neurochem       Date:  2011-09-01       Impact factor: 5.372

4.  Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent atomoxetine treatment.

Authors:  Britahny M Baskin; Bríd Á Nic Dhonnchadha; Linda P Dwoskin; Kathleen M Kantak
Journal:  Psychopharmacology (Berl)       Date:  2017-07-20       Impact factor: 4.530

5.  Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy.

Authors:  Jana D Tchekalarova; Natasha Ivanova; Dimitrina Atanasova; Daniela M Pechlivanova; Nikolai Lazarov; Lidia Kortenska; Rumiana Mitreva; Valentin Lozanov; Alexander Stoynev
Journal:  Cell Mol Neurobiol       Date:  2015-10-13       Impact factor: 5.046

6.  Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD.

Authors:  Kathleen M Kantak; Linda P Dwoskin
Journal:  Pharmacol Biochem Behav       Date:  2016-03-22       Impact factor: 3.533

7.  Set shifting in a rodent model of attention-deficit/hyperactivity disorder.

Authors:  Amy C Chess; Brittany E Raymond; Ira G Gardner-Morse; Mark R Stefani; John T Green
Journal:  Behav Neurosci       Date:  2011-06       Impact factor: 1.912

Review 8.  Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition.

Authors:  Alvin V Terry; Caterina M Hernandez; Elizabeth J Hohnadel; Kristy P Bouchard; Jerry J Buccafusco
Journal:  CNS Drug Rev       Date:  2005

Review 9.  Attention-modulating effects of cognitive enhancers.

Authors:  Edward D Levin; Philip J Bushnell; Amir H Rezvani
Journal:  Pharmacol Biochem Behav       Date:  2011-02-18       Impact factor: 3.533

10.  Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression.

Authors:  Caterina M Hernandez; Helga Høifødt; Alvin V Terry
Journal:  J Psychiatry Neurosci       Date:  2003-05       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.